Related by context. All words. (Click for frequent words.) 65 Conatus Pharmaceuticals 64 Taligen Therapeutics 64 ViroChem 64 Avila Therapeutics 63 Xanthus Pharmaceuticals Inc. 63 Viralytics 62 Trius Therapeutics 62 RxKinetix 62 Galenea 62 Sorrento Therapeutics 62 Adventrx Pharmaceuticals 62 Immuron 62 MultiCell Technologies 62 Vegenics 62 NovaBay Pharmaceuticals 62 Synergy Pharmaceuticals 62 Zenyaku Kogyo 62 MacroMed 61 Intellikine 61 SCIB1 61 Adenosine Therapeutics 61 Aeolus Pharmaceuticals 61 Cara Therapeutics 61 Alferon N 61 TRACON Pharmaceuticals 61 Cyclacel Pharmaceuticals 61 Vion Pharmaceuticals 61 NPC 1C 61 LEAD Therapeutics 61 Quark Pharmaceuticals 60 Adamis Pharmaceuticals 60 AMEX ONI 60 Genome Therapeutics 60 Akesis Pharmaceuticals 60 Oasmia 60 VentiRx 60 Presidio Pharmaceuticals 60 SinuNase ™ 60 ViroChem Pharma Inc. 60 Immunotherapeutic 60 Akebia Therapeutics 60 Astex Therapeutics 60 TapImmune 60 CAMPATH 60 Diasome 60 Chimigen TM 60 GVAX ® 60 GeneThera Inc. 60 CureDM 60 Alnylam Pharma 60 Scancell 60 AMEX RGN 60 Vaccinex 60 Napo Pharmaceuticals 59 SuperAntibody 59 Hybridon 59 Systemic Delivery 59 Virdante 59 Alnylam Nasdaq ALNY 59 Accentia Biopharmaceuticals 59 Etubics 59 Peptimmune 59 MerLion Pharmaceuticals 59 Ziopharm 59 Prima BioMed 59 InNexus Biotechnology 59 Tobira Therapeutics 59 immunotherapeutics 59 Synthetic Genomics Vaccines 59 Ophthotech 59 Therapeutic Proteins 59 AviaraDx 59 enGene 59 Monoclonal antibody 59 therapeutic monoclonal antibodies 59 Genvec 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 Aegis Therapeutics 59 AmpliMed 59 immunotherapeutic vaccine 59 Theraputics 59 novel immunotherapies 59 ImmunoVaccine Technologies 59 Adventrx 59 Aerovance 59 Celgosivir 59 Logical Therapeutics 59 Supernus Pharmaceuticals 59 Sopherion 59 Oncolys 59 ImmunoCellular Therapeutics 59 Initiates Enrollment 59 KAI Pharmaceuticals 59 Bayhill Therapeutics 59 personalized dendritic 59 Halozyme Therapeutics 59 Zelos Therapeutics 59 PAION AG ISIN 59 non nucleoside inhibitor 59 Sunesis Pharmaceuticals 59 Cethrin R 59 antiviral therapeutics 59 Salmedix 59 Nanotherapeutics 59 Epiphany Biosciences 59 ZyStor Therapeutics Inc. 59 novel immunotherapeutic 59 Epitomics 59 Portola Pharmaceuticals 59 Tesmilifene 59 Tetraphase Pharmaceuticals 59 Ilypsa 59 RECOTHROM R 59 Factor VIIa 58 ZEVALIN ® 58 Therapeutic Competitors Report 58 Maribavir 58 Anaphore 58 Hydra Biosciences 58 Metabasis Therapeutics Inc. 58 Valortim TM 58 Agios Pharmaceuticals 58 Bellicum Pharmaceuticals Inc. 58 Inovio Pharmaceuticals 58 Onconase 58 Ibis Biosciences 58 Aestus Therapeutics 58 NASDAQ OMER 58 Anticancer Agent 58 Nautilus Biotech 58 Initiates Clinical Trial 58 Ascent Therapeutics 58 Therinject 58 Creabilis Therapeutics 58 Microscience 58 Myocet 58 Alnara Pharmaceuticals 58 Personalized Immunotherapy 58 FoldRx Pharmaceuticals Inc. 58 Ore Pharmaceuticals 58 Fresenius Biotech 58 RegeneRx Biopharmaceuticals 58 mertansine 58 OTCBB CVBT 58 Idenix Pharmaceuticals 58 Cellerant 58 VitiGam 58 Ercole Biotech 58 Locus Pharmaceuticals 58 InterfeRx 58 immatics 58 Afferent Pharmaceuticals 58 OVIT 58 Cellective Therapeutics 58 MOVIPREP R 58 Chemokine Therapeutics 58 BioSeek 58 Meritage Pharma 58 JCR Pharmaceuticals 58 telaprevir VX 58 Initiates Clinical 58 Nasdaq MITI biopharmaceutical 58 miRagen 58 Kolltan Pharmaceuticals 58 VentiRx Pharmaceuticals 58 OPi 58 AEMD 58 photodisinfection 58 Aduro BioTech 58 Arqule 58 HuMax TAC 58 NanoTherapies 58 Acuity Pharmaceuticals 58 Metabasis Therapeutics 58 KaloBios 58 TolerRx 58 Paramount BioSciences 58 Aveo Pharmaceuticals 58 Mirna Therapeutics 58 MolecularMD 57 ASX PGL 57 ACE BioSciences 57 Adnavance 57 NeuroMedix 57 SYGNIS 57 humanized monoclonal 57 Koronis Pharmaceuticals 57 wholly owned immunotherapeutics 57 Epratuzumab 57 Otonomy 57 Syntonix 57 Raven Biotechnologies 57 Psivida 57 Ceragenix 57 NeuroSolutions 57 Ambrx 57 Aileron Therapeutics 57 SensiGen 57 Ichor Medical Systems 57 mSEPT9 biomarker 57 novel peptide 57 OTCBB CTIX 57 Amunix 57 Genaera Corporation 57 NASDAQ VRUS 57 Cambria Biosciences 57 Bone Biologics 57 Transcept Pharmaceuticals 57 Immunotope 57 Bellicum 57 Prism Pharmaceuticals 57 Harry Palmin President 57 VitiGam TM 57 Isis Pharma 57 Amarantus 57 Successfully Completes Phase 57 Versartis 57 Alpha Biologics 57 Microchip Biotechnologies 57 Panzem R NCD 57 Diatos 57 ACTCellerate 57 cancer immunotherapies 57 Guanilib 57 Calistoga Pharmaceuticals 57 Maxy G# 57 Ascenta Therapeutics 57 Zyngenia 57 Squalamine 57 Healionics 57 MicuRx 57 Response Biomedical 57 Evolva 57 Catalyst Biosciences 57 Harbor BioSciences 57 Apeiron Biologics 57 Takara Bio Inc. 57 Venomix 57 novel therapeutic antibodies 57 Idera Pharmaceuticals 57 OncoTherapy Science 57 prostone 57 HIV integrase inhibitor 57 Mersana 57 Hedgehog Pathway Inhibitor 57 Nasdaq CRXL 57 Merrimack Pharmaceuticals 57 JAK2 inhibitor 57 Juvaris BioTherapeutics 57 BioNumerik 57 IV Busulfex 57 CytomX Therapeutics 57 Presents Preclinical Data 57 EndoBiologics 57 Tacere 57 Neugene 57 Ironwood Pharmaceuticals 57 ARRY # 57 rxRNA 57 Septin 9 57 Pressure BioSciences 57 Oxxon 57 MBRX 57 DOS# 57 NASDAQ DIGE 57 Lexicon Pharmaceuticals 57 ProNAi 57 PNT# 57 oncolytic virus therapies 57 PharmaNova 57 Milestone Payment 57 Therapeutic Competitors Companies 57 HaptoGuard 57 oxazolidinone 57 Epizyme 57 FOLOTYN ® 57 Amira Pharmaceuticals 57 Begins Dosing 57 Syntonix Pharmaceuticals 57 NEUGENE R 57 Archexin 57 Nasdaq ENZN 57 PDE4 inhibitor 57 Monoclonal Antibodies 57 recombinant biopharmaceutical 57 Adherex Technologies 57 Initiate Clinical Trial 57 Entest BioMedical 56 NASDAQ OGXI 56 Ceflatonin R 56 Nereus Pharmaceuticals 56 Lipoxen 56 Genaco Biomedical Products 56 Small Molecule 56 LigoCyte 56 targeted radiotherapeutic 56 Anacor Pharmaceuticals 56 YM Biosciences 56 HepDirect 56 Shigamabs ® 56 Molecular Biometrics 56 Mpex 56 QuantaLife 56 Siga Technologies 56 Integrated BioTherapeutics 56 trastuzumab DM1 T DM1 56 Array Biopharma 56 Bremelanotide 56 Cancer Vaccines 56 POTELLIGENT ® 56 Chemokine 56 Neosil 56 FORMA Therapeutics 56 Innovive 56 Corixa Corporation 56 Tacere Therapeutics 56 recombinant FVIII 56 Epitome Biosystems 56 molecular imaging radiopharmaceutical 56 SR Pharma 56 Cellectar 56 deCODE chemistry 56 ProMetic BioSciences 56 Ambit Biosciences 56 Addrenex 56 cellular immunotherapy 56 Curon Medical 56 Predix Pharmaceuticals 56 Juvaris 56 CVac 56 AmpliMed Corporation 56 Aflibercept 56 Regado Biosciences 56 HCV polymerase 56 Receptos 56 Jaiva Technologies 56 Viacell 56 FASgen 56 telomerase therapeutic 56 volociximab 56 molecular chaperone regulation 56 Pathway Diagnostics 56 Antibody Discovery 56 LEUKINE 56 ProMune 56 Xenoport Inc. 56 HX Diagnostics 56 oncology therapeutics 56 NTII 56 Sangamo BioSciences 56 AION Diagnostics 56 BiolineRX 56 Phynova 56 antibody MAb 56 LymphoStat B TM 56 virosome 56 Nasdaq VRTX 56 Onyx Pharmaceuticals Inc 56 Avisio Inc. 56 InDevR 56 Enzo Therapeutics 56 Protexia R 56 Kiadis 56 A5 Labs 56 Viamet Pharmaceuticals 56 Sunshine Biopharma 56 SomaLogic 56 Nasdaq AVNR 56 Kinase Inhibitors 56 Nitazoxanide 56 Announces Poster Presentations 56 NeuVax 56 Gentronix 56 CombinatoRx Incorporated 56 Oncaspar 56 Teikoku Pharma USA 56 Daclizumab 56 APT Pharmaceuticals 56 Elixir Pharmaceuticals 56 Alder Biopharmaceuticals 56 PDL Biopharma 56 Chiral Quest 56 prophylactic vaccines 56 Æterna Zentaris 56 Veregen TM 56 X Ceptor Therapeutics 56 Milestone Payments 56 Phase 2b Clinical Trial 56 Quark Biotech Inc. 56 ART# 56 Chroma Therapeutics 56 Kerecis 56 seliciclib CYC# 56 Files IND 56 Scil Proteins 56 AltheaDx 56 tiapamil 56 Enanta Pharmaceuticals 56 Stem Cell Innovations 56 Stressgen 56 Sigma Tau Pharmaceuticals 56 Reata Pharmaceuticals 56 Lupus Drug 56 mitogen activated ERK kinase 56 SinuNase TM 56 Nasdaq SPPI 56 Tranzyme Pharma 56 Echelon Biosciences 56 Cytori Therapeutics Inc. 56 LibiGel ® 56 ValiRx 56 Chromos Molecular Systems 56 BioLife Solutions 56 PrimeGen Biotech 56 Civacir 56 Aegera 55 Biocon Limited 55 Prostate Cancer Vaccine 55 Biosyn 55 Omacetaxine 55 CyDex Pharmaceuticals 55 Exploit collaboration 55 Anadys Pharmaceuticals 55 acetonide FA 55 CoDa Therapeutics 55 Reports Preclinical Data 55 Edimer Pharmaceuticals 55 CytoDyn 55 Argenta Discovery 55 Celator 55 TOPIGEN 55 Can Fite BioPharma 55 Proteologics 55 adenosine A2A 55 Memgen 55 novel peptides 55 Zenapax 55 Idun Pharmaceuticals 55 Nasdaq IMGN 55 Capsulution 55 RayBiotech 55 OTCBB HXBM developer 55 RDYN 55 Pepscan Therapeutics 55 Initiates Phase II 55 Nasdaq MBRX 55 Bioniche Pharma Group 55 MorphoSys AG FSE MOR 55 ZymoGenetics NASDAQ ZGEN 55 InNexus 55 AMPK activators 55 HyperAcute 55 ESBATech 55 Astex Therapeutics Limited 55 Cloretazine ® 55 Arrow Therapeutics 55 HCV RNA polymerase 55 Granulocyte Colony Stimulating Factor 55 NanoViricides 55 Inc. Nasdaq IMGN 55 Mpex Pharmaceuticals 55 Bioral 55 Virulizin 55 Generex Biotechnology 55 Beerse Belgium 55 APTIMA 55 Immunicon Corporation 55 Annamycin 55 OvaRex R 55 VIRxSYS 55 iCeutica 55 Ventrus 55 Endovasc 55 RHHBY 55 glucokinase activator 55 Sirion Therapeutics 55 Phase #b/#a clinical 55 Lycera 55 SARcode Corporation 55 Regeneron Pharma 55 OncoSec 55 NASDAQ PCYC 55 Reata Pharmaceuticals Inc. 55 fluorinated carbohydrate mimics 55 IL# PE#QQR 55 PF # [002] 55 Altair Therapeutics 55 aTyr Pharma 55 RhuDex ® 55 Nuon Therapeutics 55 MAGE A3 ASCI 55 Potelligent Technology 55 Synageva BioPharma Corp. 55 Inimex 55 targeted antifolate 55 Arana Therapeutics 55 Akorn Inc 55 ChemGenex Pharmaceuticals Limited 55 PharmaVitae Profile 55 Glufosfamide 55 Dynavax proprietary 55 Oxford Genome Sciences 55 Fc fusion protein 55 EnzymeRx 55 Rigel Pharmaceuticals 55 Initiates Phase III 55 GroPep 55 ImmuneRegen BioSciences wholly owned 55 immunotherapy treatments 55 SciGen 55 Enhanze 55 Addex Pharmaceuticals SA 55 GeneOhm Sciences 55 Allozyne 55 novel synthetic peptide 55 TLR9 agonist 55 Qualified Therapeutic Discovery 55 Diffusion Pharmaceuticals 55 Trimeris Nasdaq TRMS 55 Epoch Biosciences 55 oral antiviral 55 Completes Patient Enrollment 55 BioPartners 55 Expression Genetics 55 Power3 Medical 55 Therapeutic Protein 55 GLP1 INT TM 55 Syntaxin 55 Bafetinib 55 MOLOGEN 55 Ridaforolimus 55 Enters Into Collaboration 55 Albugon 55 BioMarin Pharmaceutical 55 Hedgehog antagonist 55 Biodegradable Polymers 55 Recombinant Human 55 Illumigen Biosciences 55 Regulus Therapeutics 55 ThromboGenics NV 55 Inc. OTCBB ALRX 55 Lorus Therapeutics 55 Angiocept 55 Pervasis 55 Hepregen 55 Ltd Therapeutic Competitors 55 Leukine ® 55 Neuroptix 55 Bendamustine 55 eBioscience 55 Profectus Biosciences 55 Array BioPharma 55 Optimer Pharmaceuticals Inc 55 Oxford Immunotec 55 Gleevec imatinib mesylate 55 Tibotec BVBA 55 Crucell NV NASDAQ CRXL 55 Cardioxyl Pharmaceuticals 55 Protexia ® 55 Etravirine 55 MacroChem Corporation 55 E1 INT TM 55 Semafore Pharmaceuticals 55 Shigamabs 55 Genocea Biosciences 55 InteKrin Therapeutics 55 Allogeneic 55 BIOTECH 55 GlobeImmune 55 ChemGenex Pharmaceuticals 54 OTC BB PVCT 54 Upstream Biosciences 54 Charlesson 54 Callisto Pharmaceuticals 54 Synthetic Peptide 54 MVA BN R 54 Metaphore 54 Homspera TM 54 Nasdaq SNSS 54 EMD Biosciences Inc. 54 Neotropix 54 RenaMed Biologics 54 HUYA Bioscience International 54 Muraglitazar 54 BARRX Medical Inc. 54 SOLVAY PHARMACEUTICALS 54 HCV protease inhibitors 54 humanized antibody 54 pDNA vaccines 54 Vicuron Pharmaceuticals 54 Submits NDA 54 Bioresearch 54 Biovitrum AB 54 Protalex Inc. 54 THR beta agonist 54 Tezampanel 54 Trellis Bioscience 54 Ramoplanin 54 RECEPTORS LLC 54 Inc. Nasdaq IDMI 54 PhaseBio 54 Nipent R 54 Pluristem Therapeutics 54 antisense inhibitors 54 Chiasma 54 GW# [003] 54 ARCA biopharma 54 TKPHF 54 Interferon alfa 54 AGY Therapeutics 54 Biosimilar 54 AVEO Pharmaceuticals 54 Omthera 54 Vitro Technologies 54 Supernus Pharmaceuticals Inc. 54 Prolong Pharmaceuticals 54 Procognia 54 PDE# inhibitors 54 ImmunoCellular 54 Clavis Pharma 54 Ciphergen Biosystems 54 NASDAQ AVEO 54 NTDDS 54 PrevOnco 54 AGTC 54 Profectus BioSciences 54 Lentigen Corporation 54 Welichem 54 Alferon LDO 54 XL# XL# 54 VisEn Medical 54 ERYtech 54 Coley Pharmaceutical Group 54 Hana Biosciences 54 Genitope Corporation 54 novel histone deacetylase 54 Senexis 54 Therion Biologics 54 Spaltudaq 54 Receives Orphan Drug Designation 54 Anti Infectives 54 Novelos Therapeutics 54 thalidomide Thalomid 54 AnGes MG 54 anticancer therapeutics 54 BHT DNA 54 Tarvacin 54 nucleotide analog 54 Medivation Inc 54 Sutro Biopharma 54 Neogenix Oncology 54 Alantos Pharmaceuticals 54 Anavex #-# 54 mGluR4 PAM 54 Biotherapeutics 54 TetraLogic Pharmaceuticals 54 siRNA therapeutics 54 OPKO Health 54 Microfluidic Systems 54 cyclophilin inhibitors 54 FoldRx 54 Viamet 54 ImmunoGen Inc. 54 SMT C# 54 BUPHENYL R 54 Mipomersen 54 Sequella 54 inhaled AAT 54 Enzon Pharmaceuticals Inc 54 Onco TCS 54 NASDAQ ENMD 54 SUTIMCo 54 proprietary capillary aerosolization 54 Indaflex TM 54 Litx 54 HuMax 54 Saegis Pharmaceuticals 54 Allon Therapeutics 54 OncoVex 54 Stemgent 54 Oxford BioTherapeutics 54 Genetic Therapy 54 OncoMethylome Sciences 54 TCAD therapy 54 ORTHOCON 54 Ligand Pharma 54 Completes Dosing 54 InvestBio 54 Cabrellis 54 OncoVEX 54 OvaRex 54 CeNeRx BioPharma 54 Febuxostat 54 Cathepsin S 54 Nimblegen 54 NASDAQ DVAX 54 Biotherapeutic 54 TargeGen 54 Panzem R 54 Cobra Biomanufacturing 54 CRTX 54 Liprotamase 54 SARcode 54 Curagen 54 depsipeptide 54 Opko 54 NovaMed Pharmaceuticals 54 GRNVAC1 54 PER.C6 r 54 Resolvyx Pharmaceuticals 54 PDX pralatrexate 54 BioDelivery Sciences 54 Cylene 54 COLAZAL R 54 Cenix BioScience 54 Paradigm Genetics 54 PANVAC VF 54 Synageva 54 Alvine Pharmaceuticals 54 iPierian 54 AVAX Technologies Inc. 54 iBioPharma 54 Isotechnika Pharma 54 Othera Pharmaceuticals Inc. 54 Kapa Biosystems 54 Saforis 54 Accium BioSciences 54 Neogenix 54 Biodel BIOD 54 Pacific Biomarkers 54 Tragara Pharmaceuticals Inc. 54 Receives Milestone Payment 54 NLTX 54 JAK2 Inhibitor 54 Nasdaq DIGE News 54 Insert Therapeutics 54 Progen Pharmaceuticals Ltd 54 Phase Ib Clinical Trial 54 biologic therapeutics 54 Progenika 54 BresaGen 54 FermaVir 54 tuberculosis hepatitis B 54 Arcadia Biosciences 54 TaiGen 54 purinergic receptors P#X# 54 Cyto Pulse 54 Migenix 54 Biomarin 54 Coronado Biosciences 54 VistaGen Therapeutics 54 Cellmid 54 Saladax Biomedical 54 KaloBios Pharmaceuticals 54 Quark Pharmaceuticals Inc. 54 CardioVascular BioTherapeutics 54 HuMax HepC TM 54 NASDAQ ABII 54 Amplimmune 54 Curaxin 54 Antibody Therapeutics 54 NexGenix Pharmaceuticals 54 HemoGenix 53 Signature Genomic Laboratories 53 URG# 53 CEDAX ® 53 Intarcia 53 Nasdaq SIGA 53 Revotar 53 Evogen 53 Trubion Pharmaceuticals 53 Naurex 53 Nasdaq BSTE 53 FluoroPharma 53 Kyowa Hakko Kogyo 53 Centrose 53 Hydrogen Generation 53 ENTOCORT EC 53 Proteo 53 Odyssey Thera 53 ZFP Therapeutics 53 Viprovex TM 53 Natunola Health 53 Orphan Drugs 53 Symadex 53 Receive Milestone Payment 53 JAK3 53 oral prodrug 53 Quark Biotech 53 NEUGENE 53 BioScale 53 Optimer Pharmaceuticals 53 Elusys Therapeutics 53 Panzem 53 Elusys 53 Gemin X 53 Drug Repositioning 53 initiated Phase Ib 53 Tokai Pharmaceuticals 53 biotherapeutic drugs 53 Maas Biolab 53 Sigma Aldrich Nasdaq SIAL 53 Protalix Biotherapeutics 53 Mirus Bio 53 Intradigm 53 Receptor Logic 53 Inc. NASDAQ ZLCS 53 Avant Immunotherapeutics 53 Panbio 53 Freedom Meditech 53 initiated Phase 1b 53 PEGylated interferon 53 WaferGen Biosystems 53 Anacor 53 Aegerion Pharmaceuticals 53 MOLOGEN AG 53 KBI Biopharma 53 Acetylon 53 Aurora Kinase 53 Protein Therapeutics 53 Senomyx SNMX 53 TransTech Pharma 53 ChromoCure 53 NYSE Amex PTN 53 Nasdaq AVNC 53 transfection reagents 53 MitoKor 53 anthrax botulism typhoid 53 Angstrom Pharmaceuticals 53 Cylene Pharmaceuticals 53 CYTO 53 Optimer Pharma 53 novel anti infective 53 therapeutic monoclonal antibody 53 Cleveland Biolabs 53 Amphora Discovery 53 Submits Response 53 ATL# [002] 53 MediVas 53 Immunogen 53 UPLYSO 53 Cerashield 53 Biologics Manufacturing 53 ImQuest 53 HuMax CD#b 53 Molecular Diagnostic 53 intranasal formulation 53 Remicade infliximab 53 Adenosine Therapeutics LLC 53 Santaris 53 Guided Therapeutics Inc. 53 XmAb 53 Achillion Pharmaceuticals Inc 53 adrenergic regulation 53 DCVax R 53 CyGenics 53 GlaxoSmithKline Biologicals GSK 53 Hygeia Therapeutics 53 Bezielle 53 candidate deforolimus 53 Apitope 53 Kyto Biopharma Inc. 53 Eureka Genomics 53 rhLF 53 Nordic Biotech 53 BrachySil TM 53 Adamas Pharmaceuticals 53 NASDAQ PANC biotechnology 53 Pulmatrix 53 Orion Genomics 53 Arimoclomol 53 Vivecon 53 Receives CE Marking 53 ENZON 53 Fovea Pharmaceuticals 53 Velcura Therapeutics 53 Immunotherapeutics 53 Nurel 53 Nasdaq MNKD 53 Pink Sheets RHHBY 53 CancerVax Corporation 53 Potentia Pharmaceuticals 53 Panacos Pharmaceuticals Inc. 53 adecatumumab MT# 53 Aerie Pharmaceuticals 53 ESBATech AG 53 Humanetics 53 Affinium Pharmaceuticals 53 ARIUS 53 therapeutic antibody 53 ParAllele BioScience 53 Shanghai Wanxing 53 Piramed 53 Decision Biomarkers 53 JMAR Technologies Inc. 53 PNP inhibitor 53 Validus Pharmaceuticals 53 Accera Inc. 53 Cancer Immunotherapy 53 Inflazyme 53 TRO# 53 radiation sensitizer 53 Avantogen 53 Pure Bioscience 53 Neuren 53 Threshold Pharma 53 UMN Pharma 53 Plexera Bioscience LLC 53 Sirona Biochem 53 tubulin inhibitor 53 Athenix 53 MEK inhibitor 53 Alnylam Pharmaceuticals Inc 53 topical ophthalmic 53 XTL Biopharmaceuticals 53 BN ImmunoTherapeutics 53 Awarded Qualifying Therapeutic 53 vidofludimus 53 siRNA Delivery 53 Argolyn 53 Avian Influenza Vaccine 53 Altus Pharmaceuticals Inc. 53 ThermoDox R 53 recombinant polyclonal antibodies 53 IAP inhibitor 53 Hyaluron 53 BioSET 53 ProLindac TM 53 Stapled Peptide 53 Phase IIb clinical trials 53 Incara 53 Cethromycin 53 PhotoThera 53 Neurimmune 53 AVP #D# 53 CCR5 mAb 53 Quinamed 53 Cyntellect 53 Gliknik 53 NASDAQ PRCS 53 SIGA Technologies Inc. 53 Owlstone Nanotech 53 QRxPharma 53 Marillion Pharmaceuticals 53 Lentigen 53 Tarmogen 53 HemoGenix R 53 Selexis 53 Accelovance 53 topical anti infective 53 HTS assay 53 TriLink 53 Innovive Pharmaceuticals 53 Cerimon 53 Memryte 53 Cytomyx 53 GENR 53 Quotient Bioresearch 53 Relypsa 52 Tovaxin TM 52 Immunex Corporation 52 recombinant protein therapeutics 52 Pacira 52 Daxor Corporation 52 carbapenem 52 successfully commercialize Iluvien 52 Rubicor Medical 52 Procyon Biopharma 52 MyVax R 52 Caprion 52 Oxigene 52 KSP inhibitor 52 Xillix 52 Kun Run 52 KuDOS 52 Proteome Systems 52 Teysuno 52 Pervasis Therapeutics Inc. 52 Omnia Biologics 52 SBIR Grant 52 Xcellerated T Cells 52 investigational oral hepatitis C 52 Source MDx 52 Restanza 52 Morphotek 52 Cempra Pharmaceuticals 52 carcinoid syndrome diabetes 52 nicotinic alpha 7 52 Neutrolin ® 52 NLV Partners 52 Biologix 52 Gamunex C 52 Molecular Templates 52 Biothera 52 Varespladib 52 Euroscreen 52 BrainCells 52 NKT Therapeutics 52 MEK inhibitors